Category Specific RSS

psychedelics

Tryptamine Therapeutics’ psilocybin trials deliver pain relief to all patients

With their new name to reflect the journey their patients undergo when treated with psychedelic drugs, Tryptamine Therapeutics (ASX: TYP)…

11 months ago

Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa

In May 2023, diversified digital health company Vitura Health (ASX: VIT) announced a joint venture with Canadian psychedelic company PharmAla…

2 years ago

Treating mental health; TGA approves MDMA and Psilocybin as a medicine

Although it doesn’t apply to me, many of you may remember the early mornings during adolescence when you were throwing…

2 years ago

Does IP ownership of MDMA compounds reduce its potential for healthcare benefits?

If you read my articles often, you would know that I can become quite laudatory when discussing small cap companies…

3 years ago

Little Green Pharma to demerge its medicinal psychedelics business

There is an increasingly growing body of research globally into the use of psychedelic medicines to treat various health conditions.…

3 years ago